Treace Medical Concepts Inc 's (TMCI) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Treace Medical Concepts Inc   (NASDAQ: TMCI)
 



  Treace Medical Concepts Inc Outlook

On February 27 2024 the Treace Medical Concepts Inc provided following guidance

Treace Medical Concepts, Inc. (Treace) recently released its financial results for the fourth quarter and full year ended December 31, 2023. The company, which is listed on NasdaqGS under the ticker symbol TMCI, is a leading medical technology firm that is revolutionizing the surgical treatment of bunions and related midfoot deformities with its flagship procedures, Lapiplasty and Adductoplasty.

According to the financial report, Treace experienced strong performance in 2023, with significant growth in revenue and profits. The company's innovative procedures have gained widespread recognition in the medical community and have helped to drive its success in the market.

Looking ahead to 2024, Treace provided guidance on its expected financial performance for the year. The company is optimistic about its prospects and anticipates continued growth and success. Investors and stakeholders can expect further updates and announcements as Treace continues to make strides in the medical technology industry.

Overall, Treace Medical Concepts, Inc. remains a key player in the field of surgical treatment for bunions and midfoot deformities, and its financial performance reflects its position as a leader in this space.





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.